Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020;22(11):E911-918. doi:
10.1001/amajethics.2020.911.
The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients.
An ethical case describes an accident where a minor is killed while bungee jumping and her older brother must decide if her wishes to be an organ donor should be honored.
Physicians treating adolescents need to give them the information to make intelligent and responsible decisions regarding sexual activity and reassure them of patient confidentiality.
William E. Novotny, MD and Ronald M. Perkin, MD, MA
Physicians need to understand the resources available to them to serve the sometimes conflicting needs of the pediatric patients' best interest and the religious beliefs of the patients' parents.
Physicians need to understand the resources available to them to serve the sometimes conflicting needs of the pediatric patients' best interest and the religious beliefs of the patients' parents.
The financial generosity of the pharmaceutical industry to provide funding for medical education tempts a compromise of professional standards and ethics.
In April 2002, many pharmaceutical companies adopted PhRMA code, an attempt to self-regulate the pharmaceutical industry's marketing to physicians and other health care professionals.